◼ Archived
Business
🔮 holds ✗
The Pharma Letter
Coverage by The Pharma Letter as tracked by Newsylist.
5trends covered
0broke first
5articles tracked
◼ Archived
Business
🔮 holds ✗
Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials
◼ Archived
Business
🔮 holds ✗
Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goal
◼ Archived
Health
🔮 holds ✗
As weight loss drugs like Ozempic spread, Louisiana doctors, researchers help answer big questions
Medical researchers and clinicians are investigating whether GLP-1 weight loss drugs like Ozempic offer benefits beyond weight reduction, including longevity.
◼ Archived
Business
🔮 holds ✗
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026
Eli Lilly shares surge following a CHMP recommendation for Jaypirca's EU approval to treat chronic lymphocytic leukemia.